Business Development

Partnering with leaders

We recognise that developing and commercialising innovative therapies is not always achieved alone but as a result of partnerships. That is why we have teamed up with over 30 partners from the pharmaceutical industry.

News 2008 ›

Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate in Fibromyalgia 20-November-2008
Otsuka and UCB agreed to co-develop and co-promote Keppra® and Cimzia® in Japan 10-June-2008

Business Development & Licensing

Areas of interest UCB is seeking to expand its pipeline and product portfolio with innovative products that will treat patients suffering from severe diseases. Our areas of interest include: CNS and Immunology.
Strategic partners UCB's strategic partnerships range from joint discovery, joint development, commercialisation and manufacturing agreements with a wide range of small to large parties.
Case studies UCB has successfully partnered with leaders in the pharmaceutical industry as Pfizer, Wyeth, Biogen Idec and Jazz Pharmaceuticals.

Contact Business Development

Business Development

Partner Events 2008

JP Morgan Healthcare Conference
January 12 - 15
San Francisco, USA
http://events.jpmorgan.com

BioBusiness 2009
February 16 - 18
Geneva, Switzerland
http://www.wbresearch.com/biobusiness